logo Pharmacytics

PharmaCytics’ Nutrient-Drug-Conjugate technology (NDCt) makes drugs look like nutrients, by attaching a linker and food moiety to the active ingredient. In this way the intestinal wall recognises it as a nutrient, takes it in and once in the bloodstream the nutrient moiety is enzymatically cleaved off again – liberating the active ingredient.

We can turn many parenteral compounds in to an oral variant.

PharmaCytics’ NDC technology addresses a well recognised and widespread (⅓ of marketed- and ⅔ of R&D compounds) issue in the biopharma industry; control over PK-properties with a focus on bioavailability. The technology results in a lower attrition rate, less dismissal of effective compounds and providing a more optimal route of administration.


Transistorweg 7, building A

6534 AT Nijmegen

The Netherlands


More companies in this area

DFE Pharma

DFE Pharma develops, produces and supplies excipients for use in oral solid dose and dry powder inhalation,


Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.


TropIQ Health Sciences offers laboratory screening services for the discovery and development of drugs against malaria.

Protinhi Therapeutics

Protinhi Therapeutics is an early stage biotech company, developing novel drugs against diseases with a high unmet medical need using proprietary technology and compounds that target diseases via Protease Inhibition. The focus of Protinhi is on upcoming viral threats and particularly on Dengue and Zika.

Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.


Epigenetics is an exciting area of molecular biology that identifies key changes in gene activity that do not involve changes to the underlying genetic code.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!